Suppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent.
about
Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.Iodine uptake and prostate cancer in the TRAMP mouse model.OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro.Potential targets of energy restriction mimetic agents in cancer cells.Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice.
P2860
Suppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@en
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@nl
type
label
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@en
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@nl
prefLabel
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@en
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@nl
P2093
P2860
P1476
Suppression of prostate epithe ...... rgy restriction-mimetic agent.
@en
P2093
Brad Bolon
Ching-Shih Chen
Dasheng Wang
Lisa D Berman-Booty
Po-Chen Chu
Samuel K Kulp
Steven K Clinton
Tiffany Yang
P2860
P304
P356
10.1158/1940-6207.CAPR-12-0057
P577
2012-12-28T00:00:00Z